Wednesday - August 27, 2025
Imperial and Apollo Developing Potential Treatment for Pulmonary Hypertension
May 07, 2025
LONDON, England, May 7 -- Imperial College-London issued the following news:

* * *

Imperial and Apollo developing potential treatment for pulmonary hypertension

By David Silverman

A partnership designed to rapidly turn scientific breakthroughs into medicines has yielded a potential treatment for pulmonary arterial hypertension.

Imperial College London is working with Apollo Therapeutics to develop a prospective monoclonal antibody . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products